Joel Greenblatt Axogen, Inc. Call Options Transaction History
Gotham Asset Management, LLC
- $16.1 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AXGN
# of Institutions
177Shares Held
41.7MCall Options Held
69.1KPut Options Held
0-
First Light Asset Management, LLC Edina, MN4.53MShares$107 Million7.55% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$76.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.68MShares$63.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.51MShares$59.3 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.93MShares$45.6 Million0.03% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $998M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...